Krimine Tablets (Talniflumate)

Adult dose

Administer talniflumate 370 mg per dose orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three drinks a day; therefore, consultation with a doctor or pharmacist is necessary. Additionally, this drug can pose risks to the cardiovascular system and may increase the risk of severe cardiovascular diseases such as myocardial infarction or stroke. Individuals with a history of cardiovascular disease or those with risk factors should exercise caution and consult medical staff immediately if symptoms arise. This medication may cause serious adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, especially in the elderly or those with a history of gastrointestinal diseases. It is essential to carefully monitor for gastrointestinal symptoms during the use of this medication and seek immediate treatment if any abnormal signs occur. Individuals with a history of peptic ulcers, allergies to any of the drug's ingredients, allergies to aspirin or other non-steroidal anti-inflammatory drugs, severe liver, kidney, or heart diseases, as well as pregnant or breastfeeding women should not take this medication. Caution should be exercised in individuals with mild liver or kidney dysfunction, those taking diuretics, the elderly, and those with allergies to certain pigment constituents when using this medication. While taking this medication, various adverse reactions such as nausea, vomiting, diarrhea, abdominal pain, skin rash, hives, dizziness, renal dysfunction, etc., may occur, thus symptoms must be carefully monitored. This medication should be used at the lowest possible dose and for the shortest period. If used for an extended period, regular blood tests and liver and kidney function tests should be conducted. Co-administration with other anti-inflammatory medications should be avoided, and since there may be interactions with certain medications, it is essential to inform medical staff of any other medications being taken. Particular caution is needed during late pregnancy as this medication may harm the fetus, and those who are breastfeeding should also exercise caution when taking it. This medication is not to be used in children, especially those under 12 years old, and special attention should be given to elderly patients to avoid adverse reactions. Finally, this medication should be kept out of reach of children and is best stored in its original container to avoid confusion.

• Nausea
• vomiting
• photosensitivity
• asthma attacks
• systemic fatigue due to hypotension
• hypersensitivity shock
• diarrhea
• abdominal bloating
• constipation
• dyspepsia

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. This will help maintain the medication's efficacy over time.

Appearance

Orange round film-coated tablet

Package unit

500 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle, 100 tablets/box [10 tablets/ptp*10]